BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 31447695)

  • 1. The Potential Role of Circulating Endothelial Cells and Endothelial Progenitor Cells in the Prediction of Left Ventricular Hypertrophy in Hypertensive Patients.
    Budzyń M; Gryszczyńka B; Boruczkowski M; Kaczmarek M; Begier-Krasińska B; Osińska A; Bukowska A; Iskra M; Kasprzak MP
    Front Physiol; 2019; 10():1005. PubMed ID: 31447695
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The endothelial status reflected by circulating endothelial cells, circulating endothelial progenitor cells and soluble thrombomodulin in patients with mild and resistant hypertension.
    Budzyń M; Gryszczyńska B; Boruczkowski M; Kaczmarek M; Begier-Krasińska B; Osińska A; Bukowska A; Iskra M; Kasprzak MP
    Vascul Pharmacol; 2019 Feb; 113():77-85. PubMed ID: 30590133
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between Advanced Glycation End Products, Soluble RAGE Receptor, and Endothelium Dysfunction, Evaluated by Circulating Endothelial Cells and Endothelial Progenitor Cells in Patients with Mild and Resistant Hypertension.
    Gryszczyńska B; Budzyń M; Begier-Krasińska B; Osińska A; Boruczkowski M; Kaczmarek M; Bukowska A; Iskra M; Kasprzak MP
    Int J Mol Sci; 2019 Aug; 20(16):. PubMed ID: 31412635
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence and predictors of left ventricular hypertrophy in patients with hypertension and normal electrocardiogram.
    Nardi E; Palermo A; Mulè G; Cusimano P; Cerasola G; Rini GB
    Eur J Prev Cardiol; 2013 Oct; 20(5):854-61. PubMed ID: 22556375
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relation of echocardiographic left ventricular mass and hypertrophy to persistent electrocardiographic left ventricular hypertrophy in hypertensive patients: the LIFE Study.
    Okin PM; Devereux RB; Jern S; Julius S; Kjeldsen SE; Dahlöf B
    Am J Hypertens; 2001 Aug; 14(8 Pt 1):775-82. PubMed ID: 11497193
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Decreased circulating endothelial progenitor cell levels and function in essential hypertensive patients with electrocardiographic left ventricular hypertrophy.
    Lee CW; Huang PH; Huang SS; Leu HB; Huang CC; Wu TC; Chen JW; Lin SJ
    Hypertens Res; 2011 Sep; 34(9):999-1003. PubMed ID: 21654753
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Association between plasma microRNA-29a and left ventricular hypertrophy in patients with hypertension].
    Yao SY; Liu J; Li Y; Wang M; Wang C; Xue H
    Zhonghua Xin Xue Guan Bing Za Zhi; 2019 Mar; 47(3):215-220. PubMed ID: 30897881
    [No Abstract]   [Full Text] [Related]  

  • 8. Relationship between hypertensive left ventricular hypertrophy and levels of endothelin and nitric oxide.
    Hua L; Li C; Xia D; Qu P; Li Z; Zhang W; Feng X
    Hypertens Res; 2000 Jul; 23(4):377-80. PubMed ID: 10912776
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Validity of the ECG diagnosis of left ventricular hypertrophy in normotensive and moderately hypertensive men when using the echocardiographic assessment of left ventricular mass index as reference.
    Otterstad JE; Froeland G; Wasenius AK; Knutsen KM; Michelsen S; Stugaard M
    J Hum Hypertens; 1991 Apr; 5(2):101-6. PubMed ID: 1830106
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Four-group classification of left ventricular hypertrophy based on ventricular concentricity and dilatation identifies a low-risk subset of eccentric hypertrophy in hypertensive patients.
    Bang CN; Gerdts E; Aurigemma GP; Boman K; de Simone G; Dahlöf B; Køber L; Wachtell K; Devereux RB
    Circ Cardiovasc Imaging; 2014 May; 7(3):422-9. PubMed ID: 24723582
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ambulatory 24-hour blood pressure monitoring: correlation between blood pressure variability and left ventricular hypertrophy in untreated hypertensive patients.
    Feola M; Boffano GM; Procopio M; Reynaud S; Allemano P; Rizzi G
    G Ital Cardiol; 1998 Jan; 28(1):38-44. PubMed ID: 9493044
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Arrhythmia risk and noninvasive markers in hypertensive left ventricular hypertrophy].
    Akdeniz B; Güneri S; Badak O; Aslan O; Tamci B
    Anadolu Kardiyol Derg; 2002 Jun; 2(2):121-9; AXVII. PubMed ID: 12134537
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ECG is an inefficient screening-tool for left ventricular hypertrophy in normotensive African children population.
    Di Gioia G; Creta A; Campanale CM; Fittipaldi M; Giorgino R; Quintarelli F; Satriano U; Cruciani A; Antinolfi V; Di Berardino S; Costanzo D; Bettini R; Mangiameli G; Caricato M; Mottini G
    PeerJ; 2016; 4():e2439. PubMed ID: 27651998
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Determinants of left ventricular hypertrophy in hypertensive patients: identification of high-risk patients by metabolic, vascular, and inflammatory risk factors.
    Peer M; Boaz M; Zipora M; Shargorodsky M
    Int J Angiol; 2013 Dec; 22(4):223-8. PubMed ID: 24436616
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of free androgen index and sex hormone-binding globulin and left ventricular hypertrophy in postmenopausal hypertensive women.
    Jianshu C; Qiongying W; Ying P; Ningyin L; Junchen H; Jing Y
    J Clin Hypertens (Greenwich); 2021 Jul; 23(7):1413-1419. PubMed ID: 34105885
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intravital and postmortem diagnostics of myocardial hypertrophy of the left ventricle:identity or convention?
    Bogomolov SN; Kulikov AN; Tikhonova JA; Solntsev VN; Rybakova MG; Gudkova AY; Kuchmin AN
    Ter Arkh; 2018 Sep; 90(9):73-80. PubMed ID: 30701739
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Left ventricular hypertrophy among hypertensive patients with diminished glomerular filtration rate].
    Grabysa R; Cholewa M
    Pol Merkur Lekarski; 2008 Oct; 25(148):309-14. PubMed ID: 19145927
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Systolic left ventricular function according to left ventricular concentricity and dilatation in hypertensive patients: the Losartan Intervention For Endpoint reduction in hypertension study.
    Bang CN; Gerdts E; Aurigemma GP; Boman K; Dahlöf B; Roman MJ; Køber L; Wachtell K; Devereux RB
    J Hypertens; 2013 Oct; 31(10):2060-8. PubMed ID: 23838656
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship between Sympathetic Overactivity and Left Ventricular Hypertrophy in Resistant Hypertension.
    Özel E; Taştan A; Öztürk A; Özcan EE
    Hellenic J Cardiol; 2015; 56(6):501-6. PubMed ID: 26685294
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Left ventricular mass in hypertensive patients with mild-to-moderate reduction of renal function.
    Cerasola G; Nardi E; Mulè G; Palermo A; Cusimano P; Guarneri M; Arsena R; Giammarresi G; Carola Foraci A; Cottone S
    Nephrology (Carlton); 2010 Mar; 15(2):203-10. PubMed ID: 20470280
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.